Look Ahead

Woodcock: Compounding, Opioids, Shortages Are Key Priorities For CDER

By Beth Wang / January 13, 2020 at 5:24 PM
Opioid abuse, drug compounding and drug shortages are some of the key issues FDA’s drug center will focus on in 2020, drug center director Janet Woodcock said in an email Monday (Jan. 13). In the email, which contained few details about the agency’s future plans in each area, Woodcock laid out how FDA has already taken action on myriad issues, including postmarket safety initiatives and regulatory reform for new drugs, and she said the agency will continue that work throughout...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.